The centre has 18 partners distributed in academia, institute, industry and hospital.

The centre has two geographical nodes, Stockholm/Uppsala and Lund/Malmö.

Two partners are located outside Sweden: Ferring Pharmaceuticals in Denmark and Regenics A/S in Norway.

NexBioForm partners:

BioGaia is an innovative Swedish healthcare company and a world leader in probiotics with 28 years of experience of developing, marketing an selling probiotic products. BioGaia conducts research and development to offer consumers clinically proven, health-promoting, patented and user-friendly products. BioGaia needs access to a large variety of expertise across many different desciplins to better understand the underlying physicochemical mechanisms of biological formulations to help design innovative, user friendly products through environmental friendly, economically efficient and technically robust manufacturing processes.

Biogardia is a start-up “technology driven” company focusing on solutions to problems within the field biotechnology.

CR Competence AB is a company devoted to catalyze product and process development through the applicable use of in-depth knowledge. The company needs to combine a business savvy approach with involvement in the frontline of research for a sustainable value proposition to its clients. The company works with various businesses in different fields of which pharmaceutical product- and analytical development is an important part.

Enza Biotech AB is an R&D based company focusing on using enzymatic catalysis to develop green processes for the production of functional molecules and biobased ingredients for the personal care and health care sector. Since 2017, Enza Biotech is a subsidiary of Croda International Plc, producer of high performance ingredients in some of the most successful brands in the world.

Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Headquartered in Saint-Prex, Switzerland, Ferring has manufacturing facilities in several European countries, in South America, China, India, Israel, and USA. Founded in 1950, Ferring employs more than 6,500 people, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.

Ilya Pharma develops the next generation biologics to treat wounds in skin and mucosa. It is an innovative Swedish pharmaceutical company founded in 2016 developing drug candidates for proof of concept in clinical phase I and II from its technology platform of lactic acid bacteria expressing different human therapeutic proteins. Ilya Pharma vision is to revolutionize the field of wound care.

Lund University was founded in 1666 and is ranked among the world’s top 100 universities. The department of food technology engenering and nutrition has strong research groups within the areas of applied surface and colloid chemistry, formulation, of food and pharmaceutical, characterization of macromolecules and probiotics.

Malmö University (MAU) is an international University with an interdisciplinary approach. The Biofilms – Research Center for Biointerfaces at MAU includes strong research groups within the Material and Life Sciences with several research projects in close collaboration with national and international companies. The research is focused on phenomena related to biofilms and biologically relevant surfaces.

MAX IV Laboratory is the most modern synchrotron radiation facility in the world. Here researchers in areas such as biology, physics, chemistry, environment, geology, engineering and medicine can utilise the most brilliant X-ray light ever generated to make new discoveries and products in fields such as materials, medicine and the environment.

Regenics is an Oslo-based SME biotech company operating in the very strong marine biotech cluster of Norway. Our core business is to develop marine technologies and products for therapeutic applications such as wound healing. Regenics technology is based on the use of bioactive substances from unfertilized salmon roe cytoplasm with strong skin regenerative activity.

RISE is an independent, state-owned research institute. The Division of Bioscience and Materials has strong activities in the field of formulation for biologics both in publicly funded projects and in proprietary industrial contracts. We work with liquid and solid formulation, protein interactions at interfaces, fibrillation, as well as novel formulation platforms that enhance protein stability and formulation of probiotics. RISE promotes the innovation capacity within industry, acts as a link between academia and industry and translates basic science into innovations with benefit for industry and society.

SARomics provides premium protein crystallization, structure determination, computational chemistry and fragment-based hit generation outsourcing services. SARomics has built a global reputation for its structural biology skills and is currently supporting clients in Asia, Europe and North America to pursue their drug discovery objectives.

Sobi is an international speciality healthcare company dedicated to rare diseases. Our vision is to be recognised as a global leader in providing innovative treatments that transform life for individuals with rare diseases. The product portfolio is primarily focused on treatments in Haemophilia and Specialty Care. Sobi has pioneered in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing.

Sofus Regulatory Affairs is a life science solution provider that guide clients throughout the product life cycle. We support projects at all stages from early development to late maintenance. Sofus holds a reliable regulatory expertise and supply comprehensive regulatory, quality and safety solutions. Our consultants provide expert regulatory advice for projects within the consortium.

SOLVE R&C is a CRO working with particle analysis in both finished formulations and in difficult matrices such as blood, CSF etc. We operate globally with a strong focus on Life Science products but also covering new materials, food technology, cosmetics and environmental science. We work in close collaboration with both academia as well as with the industry.

Spiber Technologies AB is a research-based biotech company developing technologies based on the recombinant spider silk proteins Spiber® and SolvNT®. By imitating Nature’s high-performance fiber, the spider silk, we gain basic knowledge about protein folding into strong, elastic and biocompatible materials. Moreover, we are using genetic engineering to incorporate foreign elements to add desired biochemical functions to the silk materials. Our main focus is on developing protein-based materials with advanced functions for biomedical and life science applications.


Vironova is a Swedish biotechnology company specialized in nano-particle characterization for the biopharmaceutical market. Our technology is based on the combination of electron microscopy and automated image analysis. We are now expanding our technology towards a broader spectrum of biopharmaceutical applications, such as characterization of protein formulations.